For example, cDC1 cells are not considered to be abundant within the tumor microenvironment (TME), but are becoming evident in NK driven CD8+ T-cell-driven responses as potential improvement on existing therapeutics that could affect squamous cell carcinomas of the head and neck, as well as melanomas of other types [290]. Here, CD8A is linked to neoplasm.